Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GeoVax Labs (GOVX) Capital Expenditures (2017 - 2025)

Historic Capital Expenditures for GeoVax Labs (GOVX) over the last 13 years, with Q2 2025 value amounting to $10718.0.

  • GeoVax Labs' Capital Expenditures changed N/A to $10718.0 in Q2 2025 from the same period last year, while for Sep 2025 it was $27612.0, marking a year-over-year decrease of 3027.62%. This contributed to the annual value of $20653.0 for FY2024, which is 5780.45% down from last year.
  • As of Q2 2025, GeoVax Labs' Capital Expenditures stood at $10718.0.
  • In the past 5 years, GeoVax Labs' Capital Expenditures ranged from a high of $62186.0 in Q1 2022 and a low of $6192.0 during Q3 2023
  • For the 5-year period, GeoVax Labs' Capital Expenditures averaged around $25380.6, with its median value being $20197.0 (2022).
  • As far as peak fluctuations go, GeoVax Labs' Capital Expenditures surged by 102506.07% in 2021, and later tumbled by 8806.36% in 2023.
  • GeoVax Labs' Capital Expenditures (Quarter) stood at $27789.0 in 2021, then skyrocketed by 86.67% to $51875.0 in 2022, then plummeted by 63.47% to $18949.0 in 2023, then grew by 8.99% to $20653.0 in 2024, then tumbled by 48.1% to $10718.0 in 2025.
  • Its last three reported values are $10718.0 in Q2 2025, $16894.0 for Q1 2025, and $20653.0 during Q3 2024.